| Literature DB >> 31405377 |
Jing-Jing Zheng1, Jing-Hui Song2, Cong-Xiang Yu1, Fei Wang1, Peng-Cheng Wang3, Jing-Wei Meng3.
Abstract
BACKGROUND: This study aims to investigate the difference in vaginal microecology, local immunity and HPV infection among childbearing-age women with different degrees of cervical lesions.Entities:
Keywords: Cervical intraepithelial neoplasia; Cervical lesions; Cervical squamous cell carcinoma; Immune and HPV infection; Pathogen infections
Mesh:
Substances:
Year: 2019 PMID: 31405377 PMCID: PMC6689872 DOI: 10.1186/s12905-019-0806-2
Source DB: PubMed Journal: BMC Womens Health ISSN: 1472-6874 Impact factor: 2.809
The types and infection rates of HPV in the study groups and the control group
| The lesion group | High-risk type | Multiple infections | Low-risk type | Negative |
|
|---|---|---|---|---|---|
| CG | 22 (22.00) | 1 (1.00) | 3 (3.00) | 74 (74.00) | < 0.0001 |
| LSIL | 98 (72.06) | 6 (4.41) | 4 (2.94) | 28 (20.59) | |
| HSIL | 195 (74.14) | 16 (6.08) | 3 (1.14) | 49 (18.63) | |
| CSCC | 30 (90.91) | 0 (0.00) | 0 (0.00) | 3 (9.09) |
The proportion of the evaluation indexes of each vagina microecology in the study group and the control group
| Groups | Dominant fungi | Flora diversity | Flora density | Advance into enzyme | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| G + bacillus (normal) | dysbacteriosis | G + short coli (BV) | + | ++/+++ | ++++ | + | ++/+++ | ++++ | H2O2positive | SNa positive | LE positive | GUS positive | GADP positive | |
| CG | 67 (67.00) | 6 (6.00) | 27 (27.00) | 4 (4.00) | 89 (89.00) | 7 (7.00) | 4 (4.00) | 89 (89.00) | 7 (7.00) | 53 (53.00) | 11 (11.00) | 31 (31.00) | 2 (2.00) | 6 (6.00) |
| CG HPV(−) | 50 (67.57) | 6 (8.11) | 18 (24.32) | 4 (5.41) | 64 (86.49) | 6 (8.11) | 4 (5.41) | 64 (86.49) | 6 (8.11) | 38 (51.35) | 8 (10.81) | 23 (31.08) | 2 (2.70) | 5 (6.76) |
| CG HPV (+) | 17 (65.38) | 0 (0.00) | 9 (34.62) | 0 (0.00) | 25 (96.15) | 1 (3.85) | 0 (0.00) | 25 (96.15) | 1 (3.85) | 15 (57.69) | 3 (11.54) | 8 (30.77) | 0 (0.00) | 1 (3.85) |
| LSIL | 67 (49.26) | 10 (7.35) | 59 (43.38) | 8 (5.88) | 119 (87.5) | 9 (6.62) | 8 (5.88) | 119 (87.5) | 9 (6.62) | 45 (33.09) | 35 (25.74) | 60 (44.44) | 8 (5.88) | 19 (13.97) |
| HSIL | 117 (44.49) | 40 (15.21) | 106 (40.3) | 33 (12.55) | 212 (80.6) | 18 (6.84) | 33 (12.55) | 212 (80.61) | 18 (6.84) | 78 (29.66) | 40 (15.21) | 119 (45.25) | 6 (2.28) | 46 (17.49) |
| CSCC | 7 (21.21) | 20 (60.61) | 6 (18.18) | 11 (33.33) | 19 (57.6) | 3 (9.09) | 11 (33.33) | 19 (57.58) | 3 (9.09) | 17 (51.52) | 8 (24.24) | 18 (54.55) | 3 (9.09) | 9 (27.27) |
| X2 | 80.1951 | 27.926 | 27.9264 | |||||||||||
|
| <.0001 | <.0001 | <.0001 | 0.0001 | 0.0111 | 0.0737 | 0.0627 | 0.0057 | ||||||
Data are expressed as n (%)
The proportion of pathogenic microorganism infection in the study group and the control group
| Group | Trichomonad(+) | Candida(+) | The clue cells(+) | Mycoplasma(+) | Chlamydia(+) |
|---|---|---|---|---|---|
| CG | 8 (8.00) | 8 (8.00) | 11 (11.00) | 0 (0.00) | 20 (20.00) |
| CG HPV(−) | 7 (9.49) | 4 (5.41) | 10 (13.51) | 0 (0.00) | 14 (18.92) |
| CG HPV(+) | 1 (3.85) | 4 (15.38) | 1 (3.85) | 0 (0.00) | 6 (23.08) |
| LSIL | 11 (8.09) | 2 (1.47) | 25 (18.38) | 7 (5.15) | 81 (59.56) |
| HSIL | 37 (14.07) | 5 (1.90) | 68 (25.86) | 11 (4.18) | 169 (64.26) |
| CSCC | 7 (21.21) | 0 (0.00) | 9 (27.27) | 0 (0.00) | 25 (75.76) |
|
| 0.0652 | 0.0200 | 0.0086 | 0.0728 | 0.0000 |
Data are expressed as n (%)
Differences in the expression of local immune factors in the vagina in the study group and the control group
| Group | IL-2a (pg/mL) | IL-10a (ng/L) | sIgA (μg/mL) | IgGa (μg/mL) | IL-2/IL-10a |
|---|---|---|---|---|---|
| CG | 62.45 (18.23) | 30.63 (21.96) | 1.61 (0.87) | 2.92 (1.58) | 5.74 (10.22) |
| CG HPV(−) | 64.35 (16.84) | 30.78 (22.41) | 1.67 (0.94) | 2.85 (1.57) | 4.91 (5.97) |
| CG HPV(+) | 57.06 (21.15) | 30.19 (21.06) | 1.41 (0.62) | 3.12 (1.62) | 8.11 (17.36) |
| LSIL | 63.54 (21.89) | 13.41 (6.91) | 1.08 (1.35) | 3.89 (5.93) | 9.97 (14.88) |
| HSIL | 45.09 (17.07) | 18.44 (8.86) | 1.29 (1.17) | 6.62 (8.37) | 4.42 (6.24) |
| CSCC | 80.86 (72.05) | 45.88 (16.57) | 1.42 (1.01) | 6.78 (9.59) | 2.36 (2.43) |
|
| < 0.0001 | < 0.0001 | < 0.0001 | < 0.0001 | < 0.0001 |
aThe results among different groups were statistically significant
Fig. 1Different level of cervical lesions immune factor content expression differences